Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Doodipala Samba Reddy. (2013) The pathophysiological and pharmacological basis of current drug treatment of migraine headache. Expert Review of Clinical Pharmacology 6:3, pages 271-288.
Read now
Read now
Articles from other publishers (20)
You‐Jin Choi & Hee‐Jin Kim. (2022) New anatomical insights of the superficial branch of the zygomaticotemporal nerve for treating temporal migraines: An anatomical study. Clinical Anatomy 36:3, pages 406-413.
Crossref
Crossref
Kyu‐Ho Yi, Kyu‐Lim Lee, Ji‐Hyun Lee, Hye‐Won Hu & Hee‐Jin Kim. (2022) Guidance to trigger point injection for treating myofascial pain syndrome: Intramuscular neural distribution of the quadratus lumborum. Clinical Anatomy 35:8, pages 1100-1106.
Crossref
Crossref
Katarzyna Kępczyńska & Izabela Domitrz. (2022) Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches. Toxins 14:9, pages 619.
Crossref
Crossref
Kyu-Ho Yi, Ji-Hyun Lee & Hee-Jin Kim. (2022) Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome. Toxins 14:4, pages 271.
Crossref
Crossref
Kyu‐Ho Yi, Kyu‐Lim Lee, Ji‐Hyun Lee, Hye‐Won Hu, Kangwoo Lee, Kyle K. Seo & Hee‐Jin Kim. (2020) Guidelines for botulinum neurotoxin injections in piriformis syndrome. Clinical Anatomy 34:7, pages 1028-1034.
Crossref
Crossref
Shalini Shah, Michael-David Calderon, Nikhil Crain, Jason Pham & Joseph Rinehart. (2021) Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population. Regional Anesthesia & Pain Medicine 46:1, pages 41-48.
Crossref
Crossref
Mario Fernando Prieto Peres, Diego Belandrino Swerts, Arão Belitardo de Oliveira & Raimundo Pereira Silva-Neto. (2019) Migraine patients’ journey until a tertiary headache center: an observational study. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Hanieh Mimeh, Anna Maria Fenech Magrin, Simon Myers & Ali M Ghanem. (2019) A Critical Review of Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Migraine in Adults. Aesthetic Surgery Journal 39:8, pages 898-907.
Crossref
Crossref
Tiffany Y. Chen, Ivan Garza, David W. Dodick & Carrie E. Robertson. (2018) The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients. Headache: The Journal of Head and Face Pain 58:7, pages 973-985.
Crossref
Crossref
Fernando Velasco-Juanes, Juan Carlos Gómez-Esteban, Tamara Fernández-Valle, Alexandra Matute-Nieves, Javier Almeida-Velasco, Mar Irida Lloret-Villas & Iratxe Ugarriza-Serrano. (2018) Clinical treatment of chronic and episodic migraine with onabotulinumtoxinA in a real-world setting. Drugs & Therapy Perspectives 34:7, pages 335-343.
Crossref
Crossref
Thomas MuehlbergerThomas Muehlberger. 2018. Migraine Surgery. Migraine Surgery
149
173
.
Olga A. Lyubashina, Sergey S. Panteleev & Alexey Y. Sokolov. (2016) Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats. Journal of Neural Transmission 124:2, pages 171-183.
Crossref
Crossref
You-Jin Choi, Won-Jae Lee, Hyung-Jin Lee, Kang-Woo Lee, Hee-Jin Kim & Kyung-Seok Hu. (2016) Effective Botulinum Toxin Injection Guide for Treatment of Temporal Headache. Toxins 8:9, pages 265.
Crossref
Crossref
Sabine Pellett, Tony Yaksh & Roshni Ramachandran. (2015) Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing. Toxins 7:11, pages 4519-4563.
Crossref
Crossref
Adriana Johnson, Jonathan Bickel & Alyssa Lebel. (2014) Pediatric Migraine Prescription Patterns at a Large Academic Hospital. Pediatric Neurology 51:5, pages 706-712.
Crossref
Crossref
Paul G. Mathew. (2014) A Critical Evaluation of Migraine Trigger Site Deactivation Surgery. Headache: The Journal of Head and Face Pain 54:1, pages 142-152.
Crossref
Crossref
Anja Bumb, Burkhard Seifert, Stephan Wetzel & Reto Agosti. (2013) Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker. SpringerPlus 2:1.
Crossref
Crossref
Mária Dux, Péter Sántha & Gábor Jancsó. (2012) The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches. Pflügers Archiv - European Journal of Physiology 464:3, pages 239-248.
Crossref
Crossref
Sabine Pellett. (2012) Learning from the past: historical aspects of bacterial toxins as pharmaceuticals. Current Opinion in Microbiology 15:3, pages 292-299.
Crossref
Crossref
James E. Frampton. (2012) OnabotulinumtoxinA (BOTOX®). Drugs 72:6, pages 825-845.
Crossref
Crossref